A phase 3 trial of L-Glutamine in sickle cell disease

Achuta Kumar Guddati, Kota Vamsi Kota

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume379
Issue number19
DOIs
StatePublished - Nov 8 2018

Fingerprint

Sickle Cell Anemia
Glutamine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A phase 3 trial of L-Glutamine in sickle cell disease. / Guddati, Achuta Kumar; Vamsi Kota, Kota.

In: New England Journal of Medicine, Vol. 379, No. 19, 08.11.2018.

Research output: Contribution to journalLetter

@article{bb86ede5a7694f17ad20ec73ff23a5d0,
title = "A phase 3 trial of L-Glutamine in sickle cell disease",
author = "Guddati, {Achuta Kumar} and {Vamsi Kota}, Kota",
year = "2018",
month = "11",
day = "8",
doi = "10.1056/NEJMc1811050",
language = "English (US)",
volume = "379",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "19",

}

TY - JOUR

T1 - A phase 3 trial of L-Glutamine in sickle cell disease

AU - Guddati, Achuta Kumar

AU - Vamsi Kota, Kota

PY - 2018/11/8

Y1 - 2018/11/8

UR - http://www.scopus.com/inward/record.url?scp=85056423729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056423729&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1811050

DO - 10.1056/NEJMc1811050

M3 - Letter

C2 - 30406979

AN - SCOPUS:85056423729

VL - 379

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 19

ER -